Handelsavisen
prelaunch
Companies Healthcare 8406.HK
84
8406.HK HKEX Healthcare Facilities & Services

China Oral Industry Group Holdings Ltd

HK$0,05
Open in Charts → Attach watcher ⌖
HKD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
83,7M HKD
P/E
EV / Rev
Div yield
Op margin
-25,7 %
ROE
-44,2 %
Net margin
-25,5 %
Debt / equity
0,18
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

China Oral Industry Group Holdings Ltd is engaged in the pharmaceuticals industry, focusing on healthcare facilities and services, and generates revenue primarily through its operations in this sector.

Business. China Oral Industry Group Holdings Ltd (8406.HK) is a healthcare company engaged in pharmaceutical activities within the Healthcare Facilities & Services industry. The firm is listed on the Hong Kong Stock Exchange. Specific details regarding its operating segments, headquarters location, and geographic revenue mix are not available in the provided data.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryHealthcare Facilities & Services
ActivityPharmaceuticals
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
-44,2 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning 8406.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to 8406.HK. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    China Oral Industry Group Holdings Ltd (8406.HK) is a healthcare company engaged in pharmaceutical activities within the Healthcare Facilities & Services industry. The firm is listed on the Hong Kong Stock Exchange. Specific details regarding its operating segments, headquarters location, and geographic revenue mix are not available in the provided data.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryHealthcare Facilities & Services
    ActivityPharmaceuticals
    AI synthesis
    GENERATED

    The company's capital structure is characterized by a market price of 0.051 and a market cap of 83.71 million, with a price-to-book ratio of 0.87, indicating that the market value is below the book value of the company's equity. The company's liquidity is assessed as medium, with a current ratio of 2.78, suggesting it has sufficient short-term assets to cover its short-term liabilities. However, the company's net cash is negative after subtracting total debt, which raises concerns about its liquidity position.

    Profitability metrics show a challenging financial position, with a return on equity of -44.17% and a return on assets of -25.7%, both significantly below the industry median. The company reported a net loss of 42.72 million and an operating loss of 43.07 million, indicating a lack of profitability. The gross profit of 14.13 million is also low relative to its revenue of 167.65 million, suggesting high cost pressures or low pricing power.

    The company's revenue is not segmented by geographic regions or business lines in the available data, so it is not possible to assess revenue concentration or geographic exposure. However, the lack of segment data limits the ability to evaluate the company's diversification and risk profile.

    The company's growth trajectory is uncertain, as it has reported a net loss and negative operating income. There are no specific numeric deltas provided for the current or next fiscal year, but the company's financial performance suggests a lack of growth. The company's revenue history does not indicate a clear upward or downward trend, but the negative profitability metrics suggest operational challenges.

    The company's risk assessment indicates a medium liquidity risk and a low dilution risk. The key flag of negative net cash after subtracting total debt highlights the company's liquidity constraints. The dilution risk is low, and there are no specific dilution sources or expected timeframes provided in the available data.

    Recent events or filings are not detailed in the available data, so it is not possible to assess the company's recent performance or strategic direction based on disclosed events or transcripts. The lack of recent event data limits the ability to evaluate the company's current situation and future prospects.

    Key takeaways
    • The company is operating at a loss, with a net income of -42.72 million and an operating income of -43.07 million.
    • The company's market price is 0.051, and its market cap is 83.71 million, with a price-to-book ratio of 0.87.
    • The company's return on equity is -44.17%, and its return on assets is -25.7%, both significantly below the industry median.
    • The company's liquidity is assessed as medium, with a current ratio of 2.78, but it has negative net cash after subtracting total debt.
    • The company's growth trajectory is uncertain, with no specific numeric deltas provided for the current or next fiscal year.
    • The company's risk assessment indicates a medium liquidity risk and a low dilution risk.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Valuation

    Market price
    HK$0,05
    Market cap
    HK$83.7M
    Enterprise value
    HK$101.3M
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    0.9x
    P / Tangible book
    0.9x
    Tangible book
    HK$96.7M
    Net cash
    -HK$17.6M
    Current ratio
    2.8
    Debt / equity
    0.2
    ROA
    -25.7%
    ROE
    -44.2%
    Cash conversion
    CapEx / revenue
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin-25,7 %Bottom quartile
    Net Margin-25,5 %Bottom quartile
    ROE-44,2 %Bottom quartile
    D/E0,18Above median

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Return On Equity
      net_income / total_equity
    • Price To Book
      market_price / (adjusted_book_value / shares_outstanding_diluted)
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Market Price
      input from market-data provider (delayed close or quote-shim mid)
    • Market Cap
      market_price * shares_outstanding_diluted
    • Ev To Revenue
      enterprise_value / revenue
    Source documents
    • China Oral Industry Group Holdings Ltd Market data — financials · 2026-05-27

    Ownership & reference

    Leadership

    • Ping YanExecutive Chairman of the Board
    • Yao Guang LiuChief Executive Officer, Executive Director

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    8406.HKCanonical
    HKEX · HKD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    — missing data
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage